rs1981696

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000265717.5(PRKAR2B):​c.918+404C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.841 in 152,140 control chromosomes in the GnomAD database, including 53,942 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.84 ( 53942 hom., cov: 31)

Consequence

PRKAR2B
ENST00000265717.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.41

Publications

6 publications found
Variant links:
Genes affected
PRKAR2B (HGNC:9392): (protein kinase cAMP-dependent type II regulatory subunit beta) cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. This subunit has been shown to interact with and suppress the transcriptional activity of the cAMP responsive element binding protein 1 (CREB1) in activated T cells. Knockout studies in mice suggest that this subunit may play an important role in regulating energy balance and adiposity. The studies also suggest that this subunit may mediate the gene induction and cataleptic behavior induced by haloperidol. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.907 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000265717.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAR2B
NM_002736.3
MANE Select
c.918+404C>T
intron
N/ANP_002727.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAR2B
ENST00000265717.5
TSL:1 MANE Select
c.918+404C>T
intron
N/AENSP00000265717.4
PRKAR2B
ENST00000706580.1
n.1320C>T
non_coding_transcript_exon
Exon 8 of 8
PRKAR2B
ENST00000706581.1
c.678+404C>T
intron
N/AENSP00000516463.1

Frequencies

GnomAD3 genomes
AF:
0.841
AC:
127778
AN:
152022
Hom.:
53891
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.901
Gnomad AMI
AF:
0.782
Gnomad AMR
AF:
0.845
Gnomad ASJ
AF:
0.768
Gnomad EAS
AF:
0.929
Gnomad SAS
AF:
0.826
Gnomad FIN
AF:
0.840
Gnomad MID
AF:
0.782
Gnomad NFE
AF:
0.802
Gnomad OTH
AF:
0.831
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.841
AC:
127891
AN:
152140
Hom.:
53942
Cov.:
31
AF XY:
0.843
AC XY:
62672
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.901
AC:
37383
AN:
41506
American (AMR)
AF:
0.845
AC:
12927
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.768
AC:
2664
AN:
3468
East Asian (EAS)
AF:
0.929
AC:
4811
AN:
5180
South Asian (SAS)
AF:
0.826
AC:
3978
AN:
4816
European-Finnish (FIN)
AF:
0.840
AC:
8882
AN:
10578
Middle Eastern (MID)
AF:
0.786
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
0.802
AC:
54544
AN:
67974
Other (OTH)
AF:
0.832
AC:
1759
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1060
2121
3181
4242
5302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
886
1772
2658
3544
4430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.829
Hom.:
9094
Bravo
AF:
0.841
Asia WGS
AF:
0.845
AC:
2939
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
5.2
DANN
Benign
0.78
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1981696; hg19: chr7-106794100; API